Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome of Primary Prevention Implantable Cardioverter Defibrillator Therapy According to New York Heart Association Functional Classification.
Providência R, Boveda S, Defaye P, Segal O, Algalarrondo V, Sadoul N, Lambiase P, Piot O, Klug D, Perier MC, Bouzeman A, Barra S, Bories MC, Gras D, Fauchier L, Bordachar P, Babuty D, Deharo JC, Leclercq C, Marijon E; DAI-PP Investigators. Providência R, et al. Among authors: algalarrondo v. Am J Cardiol. 2016 Oct 15;118(8):1225-1232. doi: 10.1016/j.amjcard.2016.07.037. Epub 2016 Jul 29. Am J Cardiol. 2016. PMID: 27561197
Incidence and survival of transthyretin amyloid cardiomyopathy from a French nationwide study of in- and out-patient databases.
Damy T, Bourel G, Slama M, Algalarrondo V, Lairez O, Fournier P, Costa J, Pelcot F, Farrugia A, Zaleski ID, Lilliu H, Rault C, Bartoli M, Fievez S, Granghaud A, Rudant J, Coste A, Cosson CN, Squara PA, Narbeburu M, De Neuville B, Charron P. Damy T, et al. Among authors: algalarrondo v. Orphanet J Rare Dis. 2023 Nov 6;18(1):345. doi: 10.1186/s13023-023-02933-w. Orphanet J Rare Dis. 2023. PMID: 37926810 Free PMC article.
Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers.
Beauvais D, Labeyrie C, Cauquil C, Francou B, Eliahou L, Not A, Echaniz-Laguna A, Adam C, Slama MS, Benmalek A, Leonardi L, Rouzet F, Adams D, Algalarrondo V, Beaudonnet G. Beauvais D, et al. Among authors: algalarrondo v. J Neurol Neurosurg Psychiatry. 2024 May 14;95(6):489-499. doi: 10.1136/jnnp-2023-332180. J Neurol Neurosurg Psychiatry. 2024. PMID: 37875336 Free PMC article.
Effect of age on survival and causes of death after primary prevention implantable cardioverter-defibrillator implantation.
Fauchier L, Marijon E, Defaye P, Piot O, Sadoul N, Perier MC, Gras D, Klug D, Algalarrondo V, Bordachar P, Deharo JC, Leclercq C, Babuty D, Boveda S; DAI-PP Investigators. Fauchier L, et al. Among authors: algalarrondo v. Am J Cardiol. 2015 May 15;115(10):1415-22. doi: 10.1016/j.amjcard.2015.02.031. Epub 2015 Feb 18. Am J Cardiol. 2015. PMID: 25784518
Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study.
Marijon E, Leclercq C, Narayanan K, Boveda S, Klug D, Lacaze-Gadonneix J, Defaye P, Jacob S, Piot O, Deharo JC, Perier MC, Mulak G, Hermida JS, Milliez P, Gras D, Cesari O, Hidden-Lucet F, Anselme F, Chevalier P, Maury P, Sadoul N, Bordachar P, Cazeau S, Chauvin M, Empana JP, Jouven X, Daubert JC, Le Heuzey JY; CeRtiTuDe Investigators. Marijon E, et al. Eur Heart J. 2015 Nov 1;36(41):2767-76. doi: 10.1093/eurheartj/ehv455. Epub 2015 Sep 1. Eur Heart J. 2015. PMID: 26330420 Free PMC article.
103 results